MoneyWorks4Me

The revenue for the June 2022 quarter is pegged at Rs. 2715.22 millions, about 12.18% up against Rs. 2420.50 millions recorded during the year-ago period.Profit saw a slight increase of 7.40%to Rs. 201.38  millions from Rs. 187.51 millions.The company reported a good operating profit of 603.76 millions compared to 570.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2715.22 2420.50 12.18 2715.22 2420.50 12.18 9880.90 8565.78 15.35
Other Income 73.90 63.68 16.05 73.90 63.68 16.05 417.16 231.28 80.37
PBIDT 603.76 570.10 5.90 603.76 570.10 5.90 2361.90 2036.24 15.99
Interest 239.77 241.24 -0.61 239.77 241.24 -0.61 955.33 1002.16 -4.67
PBDT 363.99 328.86 10.68 363.99 328.86 10.68 1389.65 1034.08 34.39
Depreciation 162.61 140.57 15.68 162.61 140.57 15.68 1309.70 872.92 50.04
PBT 201.38 188.29 6.95 201.38 188.29 6.95 79.95 161.16 -50.39
TAX 0.00 0.78 0.00 0.00 0.78 0.00 137.05 205.16 -33.20
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -109.17 94.76 -215.21
PAT 201.38 187.51 7.40 201.38 187.51 7.40 -57.10 -44.00 29.77
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 22.24 23.55 -5.59 22.24 23.55 -5.59 23.90 23.77 0.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..